John R.P. Tesser

Jan 17, 2025 | healio.com | Rob Volansky |Shenaz Bagha |Vibeke Strand |John R.P. Tesser

You've successfully added Rheumatoid Arthritis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Nov 25, 2024 | healio.com | Rob Volansky |Shenaz Bagha |John R.P. Tesser |Nancy L. Keating

You've successfully added Practice Management in Rheumatology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. From 2011 to 2019, the proportion of rheumatologists who reported using in-house pharmacies exploded, from 4% to 22% — a more than fivefold increase.

Jul 1, 2024 | jrheum.org | Gerd R Burmester |John R.P. Tesser |Anna Shmagel |Yanxi Liu

Key Indexing Terms:arthritisclinical trialsRheumatoid arthritis (RA) is a chronic inflammatory disease that primarily affects joints, causes progressive bone and cartilage damage, and impairs quality of life if treated inadequately.1,2 The primary goal of RA therapy is to achieve sustained remission or low disease activity (LDA).

Jun 7, 2024 | healio.com | Rob Volansky |Shenaz Bagha |John R.P. Tesser

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The Mark Cuban Cost Plus Drug Company launched in January 2022 to a flurry of promises, curiosity, and a certain guarded optimism among experts regarding its potential to lower medication prices for patients.

Feb 29, 2024 | acrjournals.onlinelibrary.wiley.com | Philip Mease |Rheumatology Research |Alexis Ogdie |John R.P. Tesser

INTRODUCTION Psoriatic arthritis (PsA) is a chronic, systemic, inflammatory disease that can negatively affect patients’ health-related quality of life (HRQoL) because of pain, fatigue, psychological distress, and impaired physical function.1-3 In studies in which patients used questionnaires to rate the impact of disease on their lives, pain was ranked as the PsA symptom that most profoundly affects patients’ HRQoL,3, 4 and pain often persists despite treatment with approved therapies.5...